Why the study?
Anticancer drug-related cardiotoxicity can impair cancer treatment protocols and cause long-term adverse cardiovascular outcomes, making early detection a critical clinical target.
Does advanced cardiovascular imaging improve the early detection of chemotherapy-induced cardiotoxicity in patients receiving cancer treatments?
Design
Review
Authors
Loading...
Early cardiotoxicity surveillance in cancer patients remains essential; review leaves open optimal modality thresholds for routine practice.
Does advanced cardiovascular imaging improve the early detection of chemotherapy-induced cardiotoxicity in patients receiving cancer treatments?
Advanced imaging techniques like CMR offer critical early diagnostic capabilities for chemotherapy-induced cardiotoxicity by detecting tissue and perfusion alterations before overt functional decline.
Cannizzaro et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: